Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer

Fig. 6

Down-regulated CPT2 promotes cell proliferation in colorectal cancer. A The knockdown of CPT2 in HCT116 cells was identified by Western blotting. B, C The capability of cell proliferation of HCT116 was determined by CCK8 (B) and cell clone-formation (C) assay. D The overexpression of CPT2 in SW620 cells was identified by Western blotting. E, F The capability of cell proliferation of SW620 was determined by CCK8 (E) and cell clone-formation (F) assay. G, H The capability of cell proliferation of HCT116 (G) and SW620 (H) was determined by Edu assay. Scale bar: 50 μm. I, J Distribution of cells in three cell cycle phases of HCT116 (I) and SW620 (J) was examined by flow cytometry assay. Data are presented as mean ± SD from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us